Brandon Tudor, Dr. Al Lalos and Pete Celano of LiverRight hope to see you this week in DC at the AASLD meeting.
What’s the most prevalent yet undiagnosed specialty condition, that is VERY straightforward to diagnose and treat, and its early stages (F1 and F2) are reversible?
Liver Disease.
As you head into AASLD, Nov 7–11, one question is hard to ignore:
With ~95 million U.S. adults undiagnosed for liver disease…
who’s actually seeing them in your catchment area this month?
For most systems, the barrier isn’t clinical intent—it’s capacity. No rooms. No FTEs. No budget for a new service line lift in FY26.
That’s where LiverRight® comes in.
We operate as your virtual hepatology department, helping you stand up liver quickly and quietly behind your brand:
- Same-week tele-hepatology, branded as your hepatology service
- Fully documented in your EMR, with our hepatology providers licensed in all 50 states
- In-network by design to reduce leakage, keep patients in-system, and demonstrate clear ROI
At AASLD, let’s sit down and:
- Map the liver disease opportunity in your catchment area (~42% adult prevalence)
- Identify where patients are leaking out today
- Show how LiverRight can plug into your existing workflows without adding clinic space or FTEs.